deoxyglucose has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parris, GE | 1 |
| Brenner, B; Caro, C; Colby-Germinario, S; Germinario, RJ; Oliveira, M; Wainberg, MA | 1 |
| Barker, WW; Boothe, T; Chang, JY; Duara, R; Loewenstein, D; Pascal, S; Resnick, L; Sheldon, J; Yoshii, F | 1 |
3 other study(ies) available for deoxyglucose and HIV Coinfection
| Article | Year |
|---|---|
2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.
Topics: Animals; Antiviral Agents; Asparagine; Carbohydrates; Cell Fusion; Deoxyglucose; Drug Resistance, Viral; Glycolysis; Glycosylation; HIV Fusion Inhibitors; HIV Infections; Humans; Models, Biological; Models, Theoretical; Viral Envelope Proteins | 2008 |
Sugar transport and glut transporter expression in a variety of human immunodeficiency virus-1 (HIV-1) chronically infected target cell lines.
Topics: Biological Transport, Active; Carbohydrate Metabolism; Cell Line; Deoxyglucose; Glucose Transporter Type 1; Glucose Transporter Type 3; HIV Infections; HIV-1; Humans; Jurkat Cells; Monosaccharide Transport Proteins; Nerve Tissue Proteins; U937 Cells | 1998 |
Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings.
Topics: Adult; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; HIV Infections; HIV Seropositivity; HIV-1; Humans; Magnetic Resonance Imaging; Male; Tomography, Emission-Computed | 1991 |